Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets

References

• Rajbhar P, Gautam SS, Prasad RK, et al. Co-crystals formation of clarithromycin with urea: An efficient approach to enhance the solubility and dissolution rate. AJADD. 2016;4:12–20.
   Google Scholar
• Michael D, Feng L, Charles BD, et al. Micellar delivery of bicalutamide and embelin for treating prostate cancer. Pharm Res. 2009;26:2081–2092.
   PubMed Web of Science ®Google Scholar
• Meer T, Fule R, Khanna D, et al. Solubility modulation of bicalutamide using porous silica. J Pharm Investig. 2013;43:279–285.
   Google Scholar
• Srikanth MV, Murali Mohan Babu GV, Sreenivasa Rao N, et al. Dissolution rate enhancement of poorly soluble bicalutamide using β-cyclodextrin inclusion complexation. Int J Pharm Pharm Sci. 2010;2:191–198.
   Google Scholar
• Narkhede KB, Laware RB, Sharma YB, et al. Enhancement of solubility of bicalutamide using solid dispersion technique. Int J Pharm Sci. 2012;3:2739–2748.
   Google Scholar
• Meer TS, Sawant KP, Amin PD. Liquid antisolvent precipitation process for solubility modulation of bicalutamide. Acta Pharm. 2011;61:435–445.
   PubMed Web of Science ®Google Scholar
• Patel RP, Bhavsar VA. Studies in development of bicalutamide nano formulations. Eur J Biomed Pharm Sci. 2016;3:281–287.
   Google Scholar
• Pankaj P, Kailash B, Rao RT, et al. Micronization: an efficient tool for dissolution enhancement of dienogest. Int J Drug Dev Res. 2011;3:329–333.
   Google Scholar
• Srikanth MV, Ram BJ, Rajan DS, et al. Dissolution rate enhancement of bicalutamide by adsorption process. Afr J Pharm Pharmacol. 2013;7:1357–1362.
   Google Scholar
• El Maghraby GM, Elsergany RN. Fast disintegrating tablets of nisoldipine for intra-oral administration. Pharm Dev Technol. 2014;19:641–650.
   PubMed Web of Science ®Google Scholar
• El-Gizawy SA, Osman MA, Arafa MF, et al. Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide. Int J Pharm. 2015;478:773–778.
   PubMed Web of Science ®Google Scholar
• Nalte YK, Arsul VA, Shep SG, et al. Solubility enhancement of nevirapine by co-crystallisation technique. J Pharm Res. 2015;9:556–561.
   Google Scholar
• Budiman A, Nurlatifah E, Amin S. Enhancement of solubility and dissolution rate of glibenclamide by co crystal approach and solvent drop grinding method. Int J Curr Pharm Rev Res. 2016;7:248–250.
   Google Scholar
• Tile MK, Pawar AY. Solubility and dissolution rate enhancement of olmesartan medoxomil by chitosan based co crystal approach. Int J Pharm Bio Sci. 2015;5:400–411.
   Google Scholar
• Arafa MF, El-Gizawy SA, Osman MA, et al. Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation. J Drug Deliv Sci Technol. 2017;38:9–17.
   Web of Science ®Google Scholar
• Arafa MF, El-Gizawy SA, Osman MA, et al. Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets. Pharm Dev Technol. 2018;23:454–463.
   PubMed Web of Science ®Google Scholar
• Dengale SJ, Grohganz H, Rades T, et al. Recent advances in co-amorphous drug formulations. Adv Drug Deliv Rev. 2016;100:116–125.
   PubMed Web of Science ®Google Scholar
• Arafa MF, El-Gizawy SA, Osman MA, et al. Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets. Drug DevInd Pharm. 2016;42:1225–1233.
   PubMed Web of Science ®Google Scholar
• Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27:48–49.
   PubMed Web of Science ®Google Scholar
• Kour P, Kataria MK, Bilandi A. Dissolution rate enhancement of pioglitazone by solid dispersion technique. IAJPR. 2015;5:2664–2681.
   Google Scholar
• United States Pharmacopiae National Formulary 24. Rockville (MD): United States Pharmacopial Convention; 2000.
   Google Scholar
• Jain CP, Naruka PS. Formulation and evaluation of fast dissolving tablets of valsartan. Int J Pharm and Pharm Sci. 2009;1:219–226.
   Google Scholar
• Patil A, Pore Y, Kuchekar B. Effect of l-Arginine on bicalutamide complexation with hydroxyl propyl-β-cyclodextrin. Dig J NanomaterBio. 2008;3:89–98.
   Web of Science ®Google Scholar
• Li C, Li C, Le Y, et al. Formation of bicalutamide nanodispersion for dissolution rate enhancement. Int J Pharm. 2011;404:257–263.
   PubMed Web of Science ®Google Scholar
• Vega DR, Polla G, Martinez A, et al. Conformational polymorphism in bicalutamide. Int J Pharm. 2007;328:112–118.
   PubMed Web of Science ®Google Scholar
• Le Y, Ji H, Chen JF, et al. Nanosized bicalutamide and its molecular structure in solvents. Int J Pharm. 2009;370:175–180.
   PubMed Web of Science ®Google Scholar
• Srikanth MV, Muralimohan babu GV, Sunil SA, et al. Studies on the effect of hydrophilic carriers in the dissolution rate enhancement of poorly soluble drug, bicalutamide. Res J Pharm Tech. 2010;3:1–4.
   Google Scholar
• Basavoju S, Boström D, Velaga SP. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization. Pharm Res. 2008;25:530–541.
   PubMed Web of Science ®Google Scholar
• Goud NR, Gangavaram S, Suresh K, et al. Novel furosemide cocrystals and selection of high solubility drug forms. J Pharm Sci. 2012;101:664–680.
   PubMed Web of Science ®Google Scholar
• Shiraki K, Takata N, Takano R, et al. Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds. Pharm Res. 2008;25:2581–2592.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for industry orally disintegrating tablets – cder data standards manual. Chemistry. 2008;12:1–3.
   Google Scholar
• Mannur VS, Karki SS, Ramani KB. Formulation and characterization of ranitidine hydrochloride fast disintegrating tablets. Int J Chem Tech Res. 2010;2:1163–1169.
   Google Scholar
• Mohite BP, Chafle SA, Somasundaram J, et al. Development and evaluation of ofloxacin orally disintegrating tablets. Braz J Pharm Sci. 2012;48:217–225.
   Web of Science ®Google Scholar
• Balata GF, Zidan AS, Abourehab MAS, et al. Rapid disintegrating tablets of simvastatin dispersions in polyoxyethylene–polypropylene block copolymer for maximized disintegration and dissolution. Drug Des Devel Ther. 2016;10:3211–3223.
   PubMed Web of Science ®Google Scholar
• Essa EA, Elmarakby AO, Donia AM, et al. Controlled precipitation for enhanced dissolution rate of flurbiprofen: development of rapidly disintegrating tablets. Drug Dev Ind Pharm. 2017;43:1430–1439.
   PubMed Web of Science ®Google Scholar